RoyceDerm Psoriasis Scalp .spray.

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: RoyceDerm Psoriasis Scalp .spray.
Generic name: SALICYLIC ACID 2%
Manufacturer: RoyceDerm LLC
Product type: HUMAN OTC DRUG
SPL set ID: 57425b1a-4cf3-b133-e063-6394a90a84f5
SPL ID: 57425b1a-4cf4-b133-e063-6394a90a84f5
Version: 1
Effective date: 2026-07-23
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:41:43

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		RoyceDerm Psoriasis Scalp .spray.	openfda.brand_name
generic name		SALICYLIC ACID 2%	openfda.generic_name
manufacturer name		RoyceDerm LLC	openfda.manufacturer_name
ndc	package	85424-029-01	openfda.package_ndc
ndc	product	85424-029	openfda.product_ndc
ndc11	package	85424002901	derived:openfda.package_ndc
rxcui		2707560	openfda.rxcui
spl id		57425b1a-4cf4-b133-e063-6394a90a84f5	id
spl set id		57425b1a-4cf3-b133-e063-6394a90a84f5	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. If condition covers a large area of the body. avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. if condition worsens or does not improve after regular use of this product as directed If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.